The potential of flavonoids in the treatment of non-alcoholic fatty liver disease

References

• Abenavoli, L., Milic, N., et al. (2012). Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin. Endocrine. 42(3):754–755.
   PubMed Web of Science ®Google Scholar
• Abou El Hassan, M. A., Verheul, H. M. et al. (2003). The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro. Br. J. Cancer. 89(2):357–362.
   PubMed Web of Science ®Google Scholar
• Ae Park, S., Choi, M. S. et al. (2006). Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 79(12):1207–1213.
   PubMed Web of Science ®Google Scholar
• Ahn, T. G., Yang, G. et al. (2013). Molecular mechanisms underlying the anti-obesity potential of prunetin, an O-methylated isoflavone. Biochem. Pharmacol. 85(10):1525–1533.
   PubMed Web of Science ®Google Scholar
• Andres, S., Abraham, K. et al. (2011). Risks and benefits of dietary isoflavones for cancer. Crit. Rev. Toxicol. 41(6):463–506.
   PubMed Web of Science ®Google Scholar
• Bast, A. and Haenen, G. R. (2013). Ten misconceptions about antioxidants. Trend. Pharmacol. Sci. 34(8):430–436.
   PubMed Web of Science ®Google Scholar
• Bedogni, G., Miglioli, L. et al. (2005). Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology. 42(1):44–52.
   PubMed Web of Science ®Google Scholar
• Bieghs, V., Walenbergh, S. M. et al. (2013). Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation. Liver Int. 33(7):1056–1061.
   PubMed Web of Science ®Google Scholar
• Boots, A. W., Drent, M. et al. (2011). Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin. Nutr. 30(4):506–512.
   PubMed Web of Science ®Google Scholar
• Boots, A. W., Haenen, G. R. et al. (2008). Health effects of quercetin: From antioxidant to nutraceutical. Eur. J Pharmacol. 585(2–3):325–337.
   PubMed Web of Science ®Google Scholar
• Boots, A. W., Li, H. et al. (2007). The quercetin paradox. Toxicol. Appl. Pharmacol. 222(1):89–96.
   PubMed Web of Science ®Google Scholar
• Bors, W., Michel, C. et al. (1997). Antioxidant effects of flavonoids. Bio. Factors. 6(4):399–402.
   PubMed Web of Science ®Google Scholar
• Bose, M., Lambert, J. D. et al. (2008). The major green tea polyphenol, (−)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutr. 138(9):1677–1683.
   PubMed Web of Science ®Google Scholar
• Bruno, R. S., Dugan, C. E. et al. (2008). Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J. Nutr. 138(2):323–331.
   PubMed Web of Science ®Google Scholar
• Calani, L., Brighenti, F. et al. (2012). Absorption and metabolism of milk thistle flavanolignans in humans. Phytomedicine 20(1):40–46.
   PubMed Web of Science ®Google Scholar
• Chang, C. J., Tzeng, T. F. et al. (2011). Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARalpha levels. Planta Medica. 77(17):1876–1882.
   PubMed Web of Science ®Google Scholar
• Chen, N., Bezzina, R. et al. (2009). Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr. Res. 29(11):784–793.
   PubMed Web of Science ®Google Scholar
• Chen, Y. K., Cheung, C. et al. (2011). Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/western-style diet-induced obesity and metabolic syndrome in mice. J. Agric. Food Chem. 59(21):11862–11871.
   PubMed Web of Science ®Google Scholar
• Cho, K. W., Kim, Y. O. et al. (2011). Dietary naringenin increases hepatic peroxisome proliferators-activated receptor alpha protein expression and decreases plasma triglyceride and adiposity in rats. Eur. J. Nutr. 50(2):81–88.
   PubMed Web of Science ®Google Scholar
• Chung, M. Y., Park, H. J. et al. (2012). Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J. Nutr. Biochem. 23(4):361–367.
   PubMed Web of Science ®Google Scholar
• Conquer, J. A., Maiani, G. et al. (1998). Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr. 128(3):593–597.
   PubMed Web of Science ®Google Scholar
• Crespillo, A., Alonso, M. et al. (2011). Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity. Br. J. Pharmacol. 164(7):1899–1915.
   PubMed Web of Science ®Google Scholar
• Davis, J., Higginbotham, A. et al. (2007). Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat. Ann. Nutr. Metabol. 51(1):42–52.
   PubMed Web of Science ®Google Scholar
• Doddapattar, P., Radovic, B. et al. (2013). Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice. Mol. Nutr. Food Res. 57(10):1718–1728.
   PubMed Web of Science ®Google Scholar
• Dorn, C., Kraus, B. et al. (2010). Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Mol. Nutr. Food Res. 54(Suppl 2):S205–S213.
   PubMed Web of Science ®Google Scholar
• Duthie, G. and Crozier, A. (2000). Plant-derived phenolic antioxidants. Curr. Opin. Lipidol. 11(1):43–47.
   PubMed Web of Science ®Google Scholar
• Edwards, R. L., Lyon, T. et al. (2007). Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 137(11):2405–2411.
   PubMed Web of Science ®Google Scholar
• Egert, S., Bosy-Westphal, A. et al. (2009). Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 102(7):1065–1074.
   PubMed Web of Science ®Google Scholar
• Fenton, H. J. H. (1894). Oxidation of tartaric acid in presence of iron. J. Chem. Soc. Trans. 65:899–911.
   Google Scholar
• Ferre, P. and Foufelle, F. (2010). Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Metab. 12(Suppl 2):83–92.
   PubMed Web of Science ®Google Scholar
• Frank, J., George, T. W. et al. (2009). Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J. Nutr. 139(1):58–62.
   PubMed Web of Science ®Google Scholar
• Gao, M., Ma, Y. et al. (2013). Rutin suppresses palmitic acids-triggered inflammation in macrophages and blocks high fat diet-induced obesity and fatty liver in mice. Pharm. Res. 30(11):2940–2950.
   PubMed Web of Science ®Google Scholar
• Garcia-Lafuente, A., Guillamon, E. et al. (2009). Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflammat. Res. 58(9):537–552.
   PubMed Web of Science ®Google Scholar
• Gazak, R., Walterova, D. et al. (2007). Silybin and silymarin – new and emerging applications in medicine. Curr. Med. Chem. 14(3):315–338.
   PubMed Web of Science ®Google Scholar
• Gloire, G. and Piette, J. (2009). Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid. Redox Signal. 11(9):2209–2222.
   PubMed Web of Science ®Google Scholar
• Goldwasser, J., Cohen, P. Y. et al. (2010). Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PloS One. 5(8):e12399.
   PubMed Web of Science ®Google Scholar
• Gonzalez, R., Ballester, I. et al. (2011). Effects of flavonoids and other polyphenols on inflammation. Crit. Rev. Food Sci. Nutr. 51(4):331–362.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gallego, J., Garcia-Mediavilla, M. V. et al. (2010). Fruit polyphenols, immunity and inflammation. Br. J. Nutr. 104(Suppl. 3):S15–S27.
   PubMed Web of Science ®Google Scholar
• Goto, T., Teraminami, A. et al. (2012). Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese–diabetic mice. J. Nutr. Biochem. 23(7):768–776.
   PubMed Web of Science ®Google Scholar
• Graefe, E. U., Wittig, J. et al. (2001). Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 41(5):492–499.
   PubMed Web of Science ®Google Scholar
• Grattagliano, I., Diogo, C. V. et al. (2013). A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. World J. Gastroenterol. 19(20):3007–3017.
   PubMed Web of Science ®Google Scholar
• Gudbrandsen, O. A., Wergedahl, H., et al. (2009). A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats. Nutrition. 25(5):574–580.
   PubMed Web of Science ®Google Scholar
• Gudbrandsen, O. A., Wergedahl, H., et al. (2006). Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats. Brit. J. Nutr. 96(2):249–257.
   PubMed Web of Science ®Google Scholar
• Guo, H. X., Liu, D. H. et al. (2009). Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacol. Sinic. 30(11):1505–1512.
   Web of Science ®Google Scholar
• Guo, H., Xia, M. et al. (2012). Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. J. Nutr. Biochem. 23(4):349–360.
   PubMed Web of Science ®Google Scholar
• Haddad, Y., Vallerand, D. et al. (2011). Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evid. Based Compl. Alt. Med. 2011:nep164.
   PubMed Web of Science ®Google Scholar
• Haenen, G. R., Arts, M. J. et al. (2006). Structure and activity in assessing antioxidant activity in vitro and in vivo A critical appraisal illustrated with the flavonoids. Environ. Toxicol. Pharmacol. 21(2):191–198.
   PubMed Web of Science ®Google Scholar
• Haenen, G. R. and Bast, A. (1999). Nitric oxide radical scavenging of flavonoids. Methods Enzymol. 301:490–503.
   PubMed Web of Science ®Google Scholar
• Haenen, G. R. M. M., Jansen, F. P. et al. (1993). The antioxidant properties of five O-(β-hydroxyethyl)-rutosides of the flavonoid mixture venoruton. Phlebology. 8(suppl 1):10–17.
   Google Scholar
• Haenen, G. R. M. M., Paquay, J. B. G. et al. (1997). Peroxynitrite scavenging by flavonoids. Biochem. Biophys. Res. Commun. 236(3):591–593.
   PubMed Web of Science ®Google Scholar
• Harwood, M., Danielewska-Nikiel, B. et al. (2007). A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 45(11):2179–2205.
   PubMed Web of Science ®Google Scholar
• Heijnen, C. G., Haenen, G. R. et al. (2002). Protection of flavonoids against lipid peroxidation: The structure activity relationship revisited. Free Radic. Res. 36(5):575–581.
   PubMed Web of Science ®Google Scholar
• Heinz, S. A., Henson, D. A. et al. (2010). Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacol. Res. 62(3):237–242.
   PubMed Web of Science ®Google Scholar
• Hertog, M. G., Kromhout, D. et al. (1995). Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Internal Med. 155(4):381–386.
   PubMed Web of Science ®Google Scholar
• Higuchi, N., Kato, M. et al. (2008). Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol. Res. 38(11):1122–1129.
   PubMed Web of Science ®Google Scholar
• Hollman, P. C., de Vries, J. H. et al. (1995). Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am.J. Clin. Nutr. 62(6):1276–1282.
   PubMed Web of Science ®Google Scholar
• Hollman, P. C., vd Gaag, M. et al. (1996). Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 21(5):703–707.
   PubMed Web of Science ®Google Scholar
• Hsu, C. L., Wu, C. H. et al. (2009). Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats. J. Agric. Food Chem. 57(2):425–431.
   PubMed Web of Science ®Google Scholar
• Huang, C. S., Lii, C. K. et al. (2013). Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes. Arch. Toxicol. 87(1):167–178.
   PubMed Web of Science ®Google Scholar
• Hwang, Y. P., Choi, J. H. et al. (2011). Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice. Nutr. Res. 31(12):896–906.
   PubMed Web of Science ®Google Scholar
• Ito, M., Suzuki, J. et al. (2007). Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol. Res. 37(1):50–57.
   PubMed Web of Science ®Google Scholar
• Jacobs, B. P., Dennehy, C. et al. (2002). Milk thistle for the treatment of liver disease: A systematic review and meta-analysis. Am. J. Med. 113(6):506–515.
   PubMed Web of Science ®Google Scholar
• Javed, S., Kohli, K. et al. (2011). Reassessing bioavailability of silymarin. Altern. Med. Rev. 16(3):239–249.
   PubMed Web of Science ®Google Scholar
• Ji, G., Yang, Q. et al. (2011). Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int. Immunopharmacol. 11(6):762–768.
   PubMed Web of Science ®Google Scholar
• Jia, Y., Kim, J. Y. et al. (2013). Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid. Biochimica et Biophysica Acta. 1831(4):698–708.
   PubMed Web of Science ®Google Scholar
• Jung, C. H., Cho, I. et al. (2013). Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother. Research PTR. 27(1):139–143.
   PubMed Web of Science ®Google Scholar
• Kallwitz, E. R., McLachlan, A. et al. (2008). Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease. World J. Gastroenterol. 14(1):22–28.
   PubMed Web of Science ®Google Scholar
• Kawasaki, T., Igarashi, K. et al. (2009). Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J. Nutr. 139(11):2067–2071.
   PubMed Web of Science ®Google Scholar
• Kim, M. H., Kang, K. S. et al. (2010). The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Br. J. Nutr. 104(9):1333–1342.
   PubMed Web of Science ®Google Scholar
• Kim, H., Kong, H. et al. (2005). Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm. Res. 22(9):1499–1509.
   PubMed Web of Science ®Google Scholar
• Kim, K. D., Lee, H. J. et al. (2012). Silibinin regulates gene expression, production and secretion of mucin from cultured airway epithelial cells. Phytother. Res. PTR. 26(9):1301–1307.
   PubMed Web of Science ®Google Scholar
• Kim, M. H., Park, J. S. et al. (2011). Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int. J. Obes. 35(8):1019–1030.
   Web of Science ®Google Scholar
• Kim, M., Yang, S. G. et al. (2012). Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells. Int. J. Mol. Med. 30(3):473–479.
   PubMed Web of Science ®Google Scholar
• Kirsch, R., Clarkson, V. et al. (2003). Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J. Gastroenterol. Hepatol. 18(11):1272–1282.
   PubMed Web of Science ®Google Scholar
• Kobori, M., Masumoto, S. et al. (2011). Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a western-style diet in C57/BL6J mice. Mol. Nutr. Food Res. 55(4):530–540.
   PubMed Web of Science ®Google Scholar
• Koek, G. H., Liedorp, P. R. et al. (2011). The role of oxidative stress in non-alcoholic steatohepatitis. Clin. Chim. Acta. 412(15–16):1297–1305.
   PubMed Web of Science ®Google Scholar
• Kuzu, N., Bahcecioglu, I. H. et al. (2008). Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. J. Gastroenterol. Hepatol. 23(8, Pt 2):e465–e470.
   PubMed Web of Science ®Google Scholar
• Larkin, T., Price, W. E. et al. (2008). The key importance of soy isoflavone bioavailability to understanding health benefits. Crit. Rev. Food Sci. Nutr. 48(6):538–552.
   PubMed Web of Science ®Google Scholar
• Larter, C. Z. and Yeh, M. M. (2008). Animal models of NASH: Getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 23(11):1635–1648.
   PubMed Web of Science ®Google Scholar
• Lee, Y.-S., Cha, B.-Y. et al. (2013). Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice. J. Nutr. Biochem. 24(1):156–162.
   PubMed Web of Science ®Google Scholar
• Lee, J. W., Choe, S. S. et al. (2012). AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity. J. Lipid Res. 53(7):1277–1286.
   PubMed Web of Science ®Google Scholar
• Lee, Y. M., Choi, J. S. et al. (2006). Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition. 22(9):956–964.
   PubMed Web of Science ®Google Scholar
• Lemmens, K. J. A., Van de Wier, B. et al. (in press). The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect. Toxicol. in vitro. 28(4):538–543.
   Web of Science ®Google Scholar
• Liu, J. F., Ma, Y. et al. (2011). Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother. Res. 25(4):588–596.
   PubMed Web of Science ®Google Scholar
• Loguercio, C., Andreone, P. et al. (2012). Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. Free Radic. Biol. Med. 52(9):1658–1665.
   PubMed Web of Science ®Google Scholar
• Loguercio, C. and Festi, D. (2011). Silybin and the liver: From basic research to clinical practice. World J. Gastroenterol. 17(18):2288–2301.
   PubMed Web of Science ®Google Scholar
• Macdonald, G. A. and Prins, J. B. (2004). Peroxisomal fatty acid metabolism, peroxisomal proliferator-activated receptors and non-alcoholic fatty liver disease. J.Gastroenterol.Hepatol. 19(12):1335–1337.
   PubMed Web of Science ®Google Scholar
• Malek, M. A., Hoang, M. H. et al. (2013). Ombuin-3-O-beta-D-glucopyranoside from Gynostemma pentaphyllum is a dual agonistic ligand of peroxisome proliferator-activated receptors alpha and delta/beta. Biochem.Biophys. Res. Commun.. 430(4):1322–1328.
   PubMed Web of Science ®Google Scholar
• Manach, C., Williamson, G. et al. (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am.J.Clin. Nutr. 81(1 Suppl):230S–242S.
   PubMed Web of Science ®Google Scholar
• Mann, G. E., Bonacasa, B. et al. (2009). Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: Protection afforded by dietary isoflavones. Curr. Opin. Pharmacol. 9(2):139–145.
   PubMed Web of Science ®Google Scholar
• Manthey, J. A. (2000). Biological properties of flavonoids pertaining to inflammation. Microcirculation. 7(6, Pt 2):S29–S34.
   PubMed Web of Science ®Google Scholar
• Marcolin, E., Forgiarini, L. F. et al. (2013). Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis. Basic Clin. Pharmacol. Toxicol. 112(6):385–391.
   PubMed Web of Science ®Google Scholar
• Marcolin, E., San-Miguel, B. et al. (2012). Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. J. Nutr. 142(10):1821–1828.
   PubMed Web of Science ®Google Scholar
• Marra, F. (2008). Nuclear factor-kappaB inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy. Gut. 57(5):570–572.
   PubMed Web of Science ®Google Scholar
• Masterjohn, C. and Bruno, R. S. (2012). Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr. Rev. 70(1):41–56.
   PubMed Web of Science ®Google Scholar
• Mateo Anson, N., Aura, A. M. et al. (2011). Bioprocessing of wheat bran in whole wheat bread increases the bioavailability of phenolic acids in men and exerts antiinflammatory effects ex vivo. J. Nutr. 141(1):137–143.
   PubMed Web of Science ®Google Scholar
• Matsunami, T., Sato, Y. et al. (2010). Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis. Int. J. Clin. Exp. Pathol. 3(5):472–481.
   PubMed Web of Science ®Google Scholar
• Medjakovic, S., Mueller, M. et al. (2010). Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR. Nutrients. 2(3):241–279.
   PubMed Web of Science ®Google Scholar
• Mei, L., Mochizuki, M. et al. (2012). Hepatoprotective effects of pycnogenol in a rat model of non-alcoholic steatohepatitis. Phytother. Res. PTR. 26(10):1572–1574.
   PubMed Web of Science ®Google Scholar
• Messina, M. (2010). A brief historical overview of the past two decades of soy and isoflavone research. J. Nutr. 140(7):1350S–1354S.
   PubMed Web of Science ®Google Scholar
• Messina, M., Nagata, C. et al. (2006). Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer. 55(1):1–12.
   PubMed Web of Science ®Google Scholar
• Mohamed Salih, S., Nallasamy, P. et al. (2009). Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. J. Diabetes. 1(4):278–287.
   PubMed Web of Science ®Google Scholar
• Mulvihill, E. E., Allister, E. M. et al. (2009). Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes. 58(10):2198–2210.
   PubMed Web of Science ®Google Scholar
• Mulvihill, E. E., Assini, J. M. et al. (2010). Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler. Throm. Vascul. Biol. 30(4):742–748.
   PubMed Web of Science ®Google Scholar
• Nagarajan, P., Mahesh Kumar, M. J. et al. (2012). Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World J. Gastroenterol. 18(11):1141–1153.
   PubMed Web of Science ®Google Scholar
• Nakamoto, K., Takayama, F. et al. (2009). Beneficial effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis. J. Clin. Biochem. Nutr. 44(3):239–246.
   PubMed Web of Science ®Google Scholar
• Nanji, A. A. (2004). Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin. Liver Dis. 8(3):559–574, ix.
   PubMedGoogle Scholar
• Nelson, J. E., Wilson, L. et al. (2011). Relationship between the pattern of hepatic iron deposition and histological severity in non alcoholic fatty liver disease. Hepatology. 53(2):448–457.
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri, B. A. and Caldwell, S. H. (2003). Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology. 37(5):1202–1219.
   PubMed Web of Science ®Google Scholar
• O'Brien, J. and Powell, L. P. (2011). Non-alcoholic fatty liver disease: Is iron relevant? Hepatol. Int. 6(1):332–341.
   PubMed Web of Science ®Google Scholar
• Pais, R., Pascale, A. et al. (2011). Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. Clin. Res. Hepatol. Gastroenterol. 35(1):23–28.
   PubMed Web of Science ®Google Scholar
• Panchal, S. K., Poudyal, H. et al. (2011). Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J. Nutr. 141(6):1062–1069.
   PubMed Web of Science ®Google Scholar
• Panchal, S. K., Poudyal, H. et al. (2012). Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J. Nutr. 142(6):1026–1032.
   PubMed Web of Science ®Google Scholar
• Paquay, J. B., Haenen, G. R. et al. (2000). Protection against nitric oxide toxicity by tea. J. Agric. Food Chem. 48(11):5768–5772.
   PubMed Web of Science ®Google Scholar
• Park, H. J., DiNatale, D. A. et al. (2011). Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. J. Nutr. Biochem. 22(4):393–400.
   PubMed Web of Science ®Google Scholar
• Park, H. J., Lee, J. Y. et al. (2012). Green tea extract suppresses NFkappaB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J. Nutr. 142(1):57–63.
   PubMed Web of Science ®Google Scholar
• Pietta, P. G. (2000). Flavonoids as antioxidants. J. Nat. Prod. 63(7):1035–1042.
   PubMed Web of Science ®Google Scholar
• Polyzos, S. A., Kountouras, J. et al. (2012). Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease. J. Clin. Gastroenterol. 46(4):272–284.
   PubMed Web of Science ®Google Scholar
• Puhl, A. C., Bernardes, A. et al. (2012). Mode of peroxisome proliferator-activated receptor gamma activation by luteolin. Mol. Pharmacol. 81(6):788–799.
   PubMed Web of Science ®Google Scholar
• Qin, Y., Niu, K. et al. (2013). Isoflavones for hypercholesterolaemia in adults. Cochrane Database System. Rev. 6:CD009518.
   PubMed Web of Science ®Google Scholar
• Qin, R., Zhang, J. et al. (2012). Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats. Arch. Pharm. Res. 35(7):1241–1250.
   PubMed Web of Science ®Google Scholar
• Rolo, A. P., Teodoro, J. S. et al. (2012). Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 52:59–69.
   PubMed Web of Science ®Google Scholar
• Romestaing, C., Piquet, M. A. et al. (2007). Long-term highly saturated fat diet does not induce NASH in Wistar rats. Nutr. Metab. 4:4.
   Google Scholar
• Ronis, M. J., Chen, Y. et al. (2009). Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J. Nutr. 139(8):1431–1438.
   PubMed Web of Science ®Google Scholar
• Ross, J. A. and Kasum, C. M. (2002). Dietary flavonoids: bioavailability, metabolic effects, and safety. Ann. Rev. Nutr. 22:19–34.
   PubMed Web of Science ®Google Scholar
• Ruijters, E. J. B., Haenen, G. R. M. M. et al. (2014). The cocoa flavanol (−)-epicatechin protects the cortisol response. Pharmacol. Res. 79(0):28–33.
   PubMed Web of Science ®Google Scholar
• Russo, M., Spagnuolo, C. et al. (2012). The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83(1):6–15.
   PubMed Web of Science ®Google Scholar
• Salamone, F., Galvano, F. et al. (2012a). Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl. Res J. Lab. Clin. Med. 159(6):477–486.
   Web of Science ®Google Scholar
• Salamone, F., Galvano, F. et al. (2012b). Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Dig. Liver Dis. 44(4):334–342.
   PubMedGoogle Scholar
• Sarma, D. N., Barrett, M. L. et al. (2008). Safety of green tea extracts: A systematic review by the US Pharmacopeia. Drug Saf. Int. J. Med. Toxicol. Drug Exp. 31(6):469–484.
   PubMed Web of Science ®Google Scholar
• Savage, D. B., Tan, G. D. et al. (2003). Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes. 52(4):910–917.
   PubMed Web of Science ®Google Scholar
• Serviddio, G., Bellanti, F. et al. (2010). A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis. J. Pharmacol. Exp. Ther. 332(3):922–932.
   PubMed Web of Science ®Google Scholar
• Sharma, S., Ali, A. et al. (2013). Rutin: Therapeutic potential and recent advances in drug delivery. Expert Opin. Invest. Drugs. 22(8):1063–1079.
   PubMed Web of Science ®Google Scholar
• Sharma, A. K., Bharti, S. et al. (2011). Up-regulation of PPARgamma, heat shock protein-27 and -72 by naringin attenuates insulin resistance, beta-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br. J. Nutr. 106(11):1713–1723.
   PubMed Web of Science ®Google Scholar
• Shetty, S. N., Mengi, S. et al. (2010). A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease. J. Ayur. Integr. Med. 1(3):203–210.
   PubMedGoogle Scholar
• Shih, V. F., Tsui, R. et al. (2011). A single NFkappaB system for both canonical and non-canonical signaling. Cell Res. 21(1):86–102.
   PubMed Web of Science ®Google Scholar
• Shin, E. S., Lee, H. H. et al. (2007). Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells. J. Nutr. 137(5):1127–1131.
   PubMed Web of Science ®Google Scholar
• Shiri-Sverdlov, R., Wouters, K. et al. (2006). Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. J. Hepatol. 44(4):732–741.
   PubMed Web of Science ®Google Scholar
• Skottova, N., Vecera, R. et al. (2003). Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacol. Res. 47(1):17–26.
   PubMed Web of Science ®Google Scholar
• Song, Y. S., Fang, C. H. et al. (2013). Time course of the development of nonalcoholic Fatty liver disease in the Otsuka long-evans Tokushima fatty rat. Gastroenterol. Res. Pract. 2013:342648.
   PubMed Web of Science ®Google Scholar
• Stevenson, D. E. and Hurst, R. D. (2007). Polyphenolic phytochemicals – just antioxidants or much more? Cell. Mol. Life Sci. 64(22):2900–2916.
   PubMed Web of Science ®Google Scholar
• Sun, G. B., Sun, X. et al. (2012). Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression. Toxicol. Appl. Pharmacol. 265(2):229–240.
   PubMed Web of Science ®Google Scholar
• Tailleux, A., Wouters, K. et al. (2012). Roles of PPARs in NAFLD: potential therapeutic targets. Biochim. Biophys. Acta. 1821(5):809–818.
   PubMed Web of Science ®Google Scholar
• Takahashi, Y., Soejima, Y. et al. (2012). Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 18(19):2300–2308.
   PubMed Web of Science ®Google Scholar
• Tilg, H. and Moschen, A. R. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology. 52(5):1836–1846.
   PubMed Web of Science ®Google Scholar
• Tsuda, T., Horio, F. et al. (2003). Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J. Nutr. 133(7):2125–2130.
   PubMed Web of Science ®Google Scholar
• Ucar, F., Sezer, S. et al. (2013). The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis. Redox Rep. Comm. Free Radic. Res. 18(4):127–133.
   PubMed Web of Science ®Google Scholar
• Ueno, T., Torimura, T. et al. (2009). Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue. Int. J. Mol. Med. 24(1):17–22.
   PubMed Web of Science ®Google Scholar
• Ustundag, B., Bahcecioglu, I. H. et al. (2007). Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model. Dig. Dis. Sci. 52(8):2006–2014.
   PubMed Web of Science ®Google Scholar
• Valensi, P., Le Devehat, C. et al. (2005). A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J. Diab. Complications. 19(5):247–253.
   PubMed Web of Science ®Google Scholar
• Valenti, L., Fracanzani, A. L. et al. (2010). HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 138(3):905–912.
   PubMed Web of Science ®Google Scholar
• van Acker, F. A., Schouten, O. et al. (2000). Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett. 473(2):145–148.
   PubMed Web of Science ®Google Scholar
• van Acker, S. A., Tromp, M. N. et al. (1995). Flavonoids as scavengers of nitric oxide radical. Biochem. Biophys. Res. Communications. 214(3):755–759.
   PubMed Web of Science ®Google Scholar
• van den Berg, R., Haenen, G. R. et al. (2001). Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br. J. Nutr. 86(Suppl 1):S121–S127.
   PubMed Web of Science ®Google Scholar
• van de Wier, B., Balk, J. M. et al. (2013). Elevated citrate levels in non-alcoholic fatty liver disease: The potential of citrate to promote radical production. FEBS Lett. 587(15):2461–2466.
   PubMed Web of Science ®Google Scholar
• van Erp-Baart, M. A., Brants, H. A. et al. (2003). Isoflavone intake in four different European countries: The VENUS approach. Br. J. Nutr. 89(Suppl 1):S25–S30.
   PubMed Web of Science ®Google Scholar
• Vitale, D. C., Piazza, C. et al. (2013). Isoflavones: Estrogenic activity, biological effect, and bioavailability. Eur.J. Drug Metab. Pharmacokinet. 38(1):15–25.
   PubMed Web of Science ®Google Scholar
• Wood, N. (2004). Hepatolipidemic effects of naringenin in high corn starch- versus high coconut oil-fed rats. J. Med. Food. 7(3):315–319.
   PubMed Web of Science ®Google Scholar
• Wu, C. H., Lin, M. C. et al. (2011). Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells. J. Food Sci. 76(2):T65–T72.
   PubMed Web of Science ®Google Scholar
• Wu, J. W., Lin, L. C. et al. (2009). Drug–drug interactions of silymarin on the perspective of pharmacokinetics. J. Ethnopharmacol. 121(2):185–193.
   PubMed Web of Science ®Google Scholar
• Xia, M., Hou, M. et al. (2005). Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway. J. Biol. Chem. 280(44):36792–36801.
   PubMed Web of Science ®Google Scholar
• Xiao, J., Ho, C. T. et al. (2013). Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur. J. Nutr. 53(1):187–199.
   Web of Science ®Google Scholar
• Yalniz, M., Bahcecioglu, I. H. et al. (2007). Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J. Gastroenterol. Hepatol. 22(11):2009–2014.
   PubMed Web of Science ®Google Scholar
• Yang, Y. C., Lii, C. K. et al. (2011). Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress. Free Radic. Biol. Med. 51(11):2073–2081.
   PubMed Web of Science ®Google Scholar
• Yao, J., Zhi, M. et al. (2013). Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. Braz. J. Med. Biol. Res. 46(3):270–277.
   PubMed Web of Science ®Google Scholar
• Yao, J., Zhi, M. et al. (2011). Effect of silybin on high-fat-induced fatty liver in rats. Braz.J. Med.Biol.Res. 44(7):652–659.
   PubMed Web of Science ®Google Scholar
• Yap, F., Craddock, L. et al. (2011). Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Int. J. Biol. Sci. 7(5):645–650.
   PubMed Web of Science ®Google Scholar
• Yilmaz, Y. (2012). Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment. Pharmacol. Therapeut. 36(9):815–823.
   PubMed Web of Science ®Google Scholar
• Ying, H. Z., Liu, Y. H. et al. (2013). Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food Chem. Toxicol. 52:53–60.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Cui, W. et al. (2012). Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCalpha and PI3K/AKT signaling pathways. J. Agric. Food Chem. 60(33):8171–8182.
   PubMed Web of Science ®Google Scholar
• Zheng, P., Ji, G. et al. (2009). Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. Am. J.. Chin. Med. 37(1):69–83.
   PubMed Web of Science ®Google Scholar
• Zhu, W., Jia, Q. et al. (2012). The anthocyanin cyanidin-3-O-beta-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: Involvement of a cAMP-PKA-dependent signaling pathway. Free Radic. Biol. Med. 52(2):314–327.
   PubMed Web of Science ®Google Scholar
• Ziaee, A., Zamansoltani, F. et al. (2009). Effects of rutin on lipid profile in hypercholesterolaemic rats. Basic Clin. Pharmacol. Toxicol. 104(3):253–258.
   PubMed Web of Science ®Google Scholar